Figure 2.
(a) An anterior-oblique approach to the sacral body and alae simultaneously was selected, and (b) PMMA was injected into the anterior third of the sacral body for distribution within the body of S1 and S2. (c) post-injection fluoroscopy shows no extension towards the sacral canal, the neural foramina, or beyond the bone margins.
